BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 23401248)

  • 1. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
    Mangge H; Zelzer S; Puerstner P; Schnedl WJ; Reeves G; Postolache TT; Weghuber D
    Obesity (Silver Spring); 2013 Jan; 21(1):E71-7. PubMed ID: 23401248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk vs. "metabolically healthy" phenotype in juvenile obesity - neck subcutaneous adipose tissue and serum uric acid are clinically relevant.
    Weghuber D; Zelzer S; Stelzer I; Paulmichl K; Kammerhofer D; Schnedl W; Molnar D; Mangge H
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):384-90. PubMed ID: 23519645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome-Unaltered in Young and not Correlated to Carotid IMT in All Ages.
    Mangge H; Zelzer S; Meinitzer A; Stelzer I; Schnedl WJ; Weghuber D; Fuchs D; Postolache TT; Aigner E; Datz C; Reininghaus EZ
    Curr Pharm Des; 2015; 21(17):2243-9. PubMed ID: 25557634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the association of leptin and adiponectin concentrations with metabolic syndrome in children: Results from the IDEFICS study.
    Nappo A; González-Gil EM; Ahrens W; Bammann K; Michels N; Moreno LA; Kourides Y; Iacoviello L; Mårild S; Fraterman A; Molnàr D; Veidebaum T; Siani A; Russo P
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):543-551. PubMed ID: 28511904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity.
    Genoni G; Menegon V; Secco GG; Sonzini M; Martelli M; Castagno M; Ricotti R; Monzani A; Aronici M; Grossini E; Di Mario C; Bona G; Bellone S; Prodam F
    Int J Cardiol; 2017 Dec; 249():366-371. PubMed ID: 28935462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From metabolic normality to cardiometabolic risk factors in subjects with obesity.
    Bobbioni-Harsch E; Pataky Z; Makoundou V; Laville M; Disse E; Anderwald C; Konrad T; Golay A;
    Obesity (Silver Spring); 2012 Oct; 20(10):2063-9. PubMed ID: 22421925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects.
    Yosaee S; Khodadost M; Esteghamati A; Speakman JR; Shidfar F; Nazari MN; Bitarafan V; Djafarian K
    Am J Mens Health; 2017 Mar; 11(2):426-434. PubMed ID: 27550773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is adiposity at normal body weight relevant for cardiovascular disease risk?
    Tanaka S; Togashi K; Rankinen T; Pérusse L; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
    Int J Obes Relat Metab Disord; 2002 Feb; 26(2):176-83. PubMed ID: 11850748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution.
    Marsche G; Zelzer S; Meinitzer A; Kern S; Meissl S; Pregartner G; Weghuber D; Almer G; Mangge H
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4117-4123. PubMed ID: 28938424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precocious Preclinical Cardiovascular Sonographic Markers in Metabolically Healthy and Unhealthy Childhood Obesity.
    Corica D; Oreto L; Pepe G; Calabrò MP; Longobardo L; Morabito L; Pajno GB; Alibrandi A; Aversa T; Wasniewska M
    Front Endocrinol (Lausanne); 2020; 11():56. PubMed ID: 32194501
    [No Abstract]   [Full Text] [Related]  

  • 14. Leptin as a cardiovascular risk marker in metabolically healthy obese: Hyperleptinemia in metabolically healthy obese.
    Jamar G; Caranti DA; de Cassia Cesar H; Masquio DCL; Bandoni DH; Pisani LP
    Appetite; 2017 Jan; 108():477-482. PubMed ID: 27838444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers.
    Zelzer S; Fuchs N; Almer G; Raggam RB; Prüller F; Truschnig-Wilders M; Schnedl W; Horejsi R; Möller R; Weghuber D; Ille R; Mangge H
    Clin Chim Acta; 2011 Jul; 412(15-16):1345-9. PubMed ID: 21515245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity.
    Kelly AS; Metzig AM; Schwarzenberg SJ; Norris AL; Fox CK; Steinberger J
    Metab Syndr Relat Disord; 2012 Apr; 10(2):123-7. PubMed ID: 22217186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.
    Petrikova J; Janicko M; Fedacko J; Drazilova S; Madarasova Geckova A; Marekova M; Pella D; Jarcuska P
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29973567
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum adiponectin, body adiposity and metabolic parameters in obese Egyptian children with Down syndrome.
    Yahia S; El-Farahaty R; El-Gilany AH; Shoaib R; Ramadan R; Salem N
    J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1401-1410. PubMed ID: 34348423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome.
    Baer TE; Milliren CE; Walls C; DiVasta AD
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):317-23. PubMed ID: 26081478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.
    Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ
    Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.